Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody
血清可溶性 CD26/DPP4 滴度变化是人源化抗 CD26 抗体治疗癌症的潜在预后生物标志物
期刊:Biomarker Research
影响因子:9.5
doi:10.1186/s40364-021-00273-0
Yutaro Kaneko, Ryo Hatano, Naoto Hirota, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Fanny Valleix, Thomas Podoll, Yoshimi Umezawa, Seiichi Takao, Satoshi Iwata, Osamu Hosono, Tetsuo Taguchi, Taketo Yamada, Nam H Dang, Kei Ohnuma, Eric Angevin, Chikao Mo